Abstract
Background: Numerous unfavorable obstetric outcomes have been connected to valvular heart disease when combined with the considerable hemodynamic changes of pregnancy. Aim: This paper was objective to evaluate of valvular heart outcomes and its impact on Iraqi women and the newborn fetus. Patients and methods: The databases were organized from different hospitals in Iraq between 16th March 2021 to 18th April 2022. This study was encouraged to evaluate of valvular heart outcomes and its impact on Iraqi women and the newborn fetus. In the methodology of the study, this study was interested as a cross-sectional study into identifying of women and newborn fetus under the ages of 25-40 years for 80 patients. This study was divided into two groups which are the Mechanical group (40) and the Bioprosthetic group (40). This paper was analysed the databases outcomes by the SPSS program. Results and discussion: We compared the maternal and fetal results of pregnancy with mechanical vs. bioprosthetic heart valves utilizing a nationally representative sample of patients who had previously undergone valve replacement. MHVs were present in almost 60% of those who had prosthetic limbs. Patients with any kind of prosthesis had nearly 15 times the probability of developing MACE compared to the general pregnant population, as well as longer hospital stays and higher healthcare expenses. Even after adjusting for baseline variables, the probability for MACE and any other adverse maternal event remained equal between those with MHVs and BHVs. Both valve types had a comparable risk of prenatal problems, such as congenital abnormalities and stillbirth. Several of these conclusions need for more elaboration. Conclusion: Our study found no big difference between the mechanical group and the bioprosthetic group, where mechanical group complications were higher than the bioprosthetic group in maternal and fetal outcomes. The disadvantages result of analyses 95 CI were related to mechanical more than bioprosthetic
Keywords
Maternal and newborn fetus outcomes; Bioprosthetic group; and Mechanical group